Psychosocial and ethical implications of defining genetic risk for cancers.
In summary, we need to provide fully informed consent regarding the hazards and the benefits of genetic testing and defining risk. This reflects the first ethical principle of autonomy. It is the responsibility of the counseling team to make sure that the individual is psychologically equipped to deal with the emotional distress that may result from testing. An undue burden must not be placed on someone and harm must not be inflicted. This is the second ethical principle of beneficence. Third, awareness of the potential problems of testing is extremely important. These issues are those of disclosure, insurance problems, and employment problems--the third ethical principle of confidentiality. Recommendations for screening guidelines, regardless of testing results, should be provided. It is important for women who are not gene carriers to know that they still need to go for screening. Lastly, we need to find ways to help individuals cope with their risk status, whether it is actual high risk or perceived high risk. Helping women to develop positive coping strategies and to adhere to screening is extremely important. As the Huntington's data indicated, over time, regardless of their risk levels, individuals do learn how to cope and adapt with the outcome of testing. Women and men need to learn how to live with their risk status so that the negative psychological sequelae will be minimized.
Kash
K M
KM
Strang Cancer Prevention Center, New York, New York 10021, USA.
D000328:Adult; D001294:Attitude to Health; D001675:Bioethics; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D032882:Comprehension; D030881:Disclosure; D004995:Ethics, Professional; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics; D007258:Informed Consent; D008297:Male; D008327:Mammography / Q000523:psychology; D008403:Mass Screening; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics*; D010375:Pedigree; D011237:Predictive Value of Tests; D012307:Risk Factors